Literature DB >> 17073604

Transposons for gene therapy!

Zoltán Ivics1, Zsuzsanna Izsvák.   

Abstract

Gene therapy is a promising strategy for the treatment of several inherited and acquired human diseases. Several vector platforms exist for the delivery of therapeutic nucleic acids into cells. Vectors based on viruses are very efficient at introducing gene constructs into cells, but their use has been associated with genotoxic effects of vector integration or immunological complications due to repeated administration in vivo. Non-viral vectors are easier to engineer and manufacture, but their efficient delivery into cells is a major challenge, and the lack of their chromosomal integration precludes long-term therapeutic effects. Transposable elements are non-viral gene delivery vehicles found ubiquitously in nature. Transposon-based vectors have the capacity of stable genomic integration and long-lasting expression of transgene constructs in cells. Molecular reconstruction of Sleeping Beauty, an ancient transposon in fish, represents a cornerstone in applying transposition-mediated gene delivery in vertebrate species, including humans. This review summarizes the state-of-the-art in the application of transposable elements for therapeutic gene transfer, and identifies key targets for the development of transposon-based gene vectors with enhanced efficacy and safety for human applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17073604     DOI: 10.2174/156652306778520647

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  52 in total

1.  Sleeping Beauty jumps to new heights.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2010-07       Impact factor: 4.599

2.  Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells.

Authors:  Xin Huang; Hongfeng Guo; Syam Tammana; Yong-Chul Jung; Emil Mellgren; Preetinder Bassi; Qing Cao; Zheng Jin Tu; Yeong C Kim; Stephen C Ekker; Xiaolin Wu; San Ming Wang; Xianzheng Zhou
Journal:  Mol Ther       Date:  2010-07-06       Impact factor: 11.454

3.  Intrinsic characteristics of neighboring DNA modulate transposable element activity in Drosophila melanogaster.

Authors:  Caroline Esnault; Azhahianambi Palavesam; Kristina Pilitt; David A O'Brochta
Journal:  Genetics       Date:  2010-10-13       Impact factor: 4.562

4.  Crystallization of a Mos1 transposase-inverted-repeat DNA complex: biochemical and preliminary crystallographic analyses.

Authors:  Julia M Richardson; David J Finnegan; Malcolm D Walkinshaw
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-04-20

Review 5.  Mariner transposons as genetic tools in vertebrate cells.

Authors:  L Delaurière; B Chénais; Y Hardivillier; L Gauvry; N Casse
Journal:  Genetica       Date:  2009-05-29       Impact factor: 1.082

Review 6.  Integration-deficient lentiviral vectors: a slow coming of age.

Authors:  Klaus Wanisch; Rafael J Yáñez-Muñoz
Journal:  Mol Ther       Date:  2009-06-02       Impact factor: 11.454

Review 7.  Targeted gene insertion for molecular medicine.

Authors:  Katrin Voigt; Zsuzsanna Izsvák; Zoltán Ivics
Journal:  J Mol Med (Berl)       Date:  2008-07-08       Impact factor: 4.599

Review 8.  Gene therapy vectors: the prospects and potentials of the cut-and-paste transposons.

Authors:  Corentin Claeys Bouuaert; Ronald M Chalmers
Journal:  Genetica       Date:  2009-08-02       Impact factor: 1.082

9.  A resurrected mammalian hAT transposable element and a closely related insect element are highly active in human cell culture.

Authors:  Xianghong Li; Hosam Ewis; Robert H Hice; Nirav Malani; Nicole Parker; Liqin Zhou; Cédric Feschotte; Frederic D Bushman; Peter W Atkinson; Nancy L Craig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

10.  De novo induction of genetically engineered brain tumors in mice using plasmid DNA.

Authors:  Stephen M Wiesner; Stacy A Decker; Jon D Larson; Katya Ericson; Colleen Forster; Jose L Gallardo; Chunmei Long; Zachary L Demorest; Edward A Zamora; Walter C Low; Karen SantaCruz; David A Largaespada; John R Ohlfest
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.